Vanderson Rocha

717 total citations
19 papers, 459 citations indexed

About

Vanderson Rocha is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Vanderson Rocha has authored 19 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 4 papers in Genetics. Recurrent topics in Vanderson Rocha's work include Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Vanderson Rocha is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Vanderson Rocha collaborates with scholars based in Brazil, France and United States. Vanderson Rocha's co-authors include Patricia Ribaud, Jean‐Paul Latgé, Gérard Socié, Nathalie Parquet, Claude Chastang, Francis Derouin, Éliane Gluckman, Francesco Frassoni, Jaak M. Vossen and Katarina Le Blanc and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Vanderson Rocha

16 papers receiving 451 citations

Peers

Countries citing papers authored by Vanderson Rocha

Since Specialization

Citations

This map shows the geographic impact of Vanderson Rocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanderson Rocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanderson Rocha more than expected).

Fields of papers citing papers by Vanderson Rocha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanderson Rocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanderson Rocha. The network helps show where Vanderson Rocha may publish in the future.

Co-authorship network of co-authors of Vanderson Rocha

This figure shows the co-authorship network connecting the top 25 collaborators of Vanderson Rocha. A scholar is included among the top collaborators of Vanderson Rocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanderson Rocha. Vanderson Rocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial 2025 ·Leukemia ·Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Vanderson Rocha, Cristina Papayannidis, Jessica Leonard, Maria R. Baer, Josep‐María Ribera, James A. McCloskey, Jianxiang Wang, Sujun Gao, (unknown), Shien Guo	0
2	Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacterales and Bacteremia in Hematopoietic Stem Cell Transplant Recipients 2024 ·Antibiotics ·(unknown), (unknown), Bruno de Melo Tavares, (unknown), Marina Farrel Côrtes, (unknown), (unknown), (unknown), (unknown), Fernanda Spadão, Vanderson Rocha, Thaís Guimarães, Sílvia Figueiredo Costa	1
3	COVID-19 in hematopoietic stem cell transplant recipients during three years of the pandemic: a multicenter study in Brazil 2024 ·Revista do Instituto de Medicina Tropical de São Paulo ·(unknown), (unknown), (unknown), Matias Chiarastelli Salomão, Antônio Carlos Campos Pignatari, Edson Abdala, (unknown), (unknown), (unknown), Carolina dos Santos Lázari, José Eduardo Levi, (unknown), Marina Farrel Côrtes, (unknown), Vanderson Rocha, Sílvia Figueiredo Costa	0
4	Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study 2023 ·Blood ·Ibrahim Aldoss, Josep‐María Ribera, Hagop M. Kantarjian, Pau Montesinos, Jessica Leonard, David Gómez‐Almaguer, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Meliessa Hennessy, (unknown), Alexander Vorog, Bingxia Wang, Elias Jabbour	2
5	High Tuberculosis density incidence rate in Matched Unrelated Allogeneic stemcell transplantation recipients in the state of São Paulo, Brazil 2023 ·Mediterranean Journal of Hematology and Infectious Diseases ·Marcelo Nóbrega Litvoc, Sílvia Figueiredo Costa, Fábio E. Leal, (unknown), Max Igor Banks Ferreira Lopes, Ligia Capuani, Vanderson Rocha	0
6	First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). 2023 ·Journal of Clinical Oncology ·Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica Leonard, David Gómez‐Almaguer, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Bingxia Wang, Meliessa Hennessy, Alexander Vorog, (unknown), Josep‐María Ribera	11
7	HAPLOIDENTICAL STEM CELL TRANSPLANTATION 2021 ·Giancarlo Fatobene, (unknown), Nelson Hamerschlak, Vanderson Rocha	1
8	Challenges in Diagnosis and Treatment of Systemic Amyloidosis: 10 Years of Experience in a Public Brazilian University Center 2020 ·Blood ·(unknown), Fábio Fernandes, (unknown), Angelina Maria Martins Lino, (unknown), Leonardo Oliveira Mendonça, (unknown), Jussara Bianchi Castelli, Eduardo Magalhães Rego, (unknown), (unknown), (unknown), Vanderson Rocha	1
9	Outcomes and second neoplasms in hairy cell leukemia: A retrospective cohort 2019 ·Leukemia Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Elvira Deolinda Rodrigues Pereira Velloso, Eduardo Magalhães Rego, Vanderson Rocha, Valéria Buccheri	7
10	Autoimmune manifestations in SCID due to IL7R mutations: Omenn syndrome and cytopenias 2014 ·Human Immunology ·Cláudia Augusta Zago, Cristina Miuki Abe Jacob, Edna Maria de Albuquerque Diniz, Silvana Maria Lovisolo, Maria Cláudia Nogueira Zerbini, (unknown), (unknown), Juliana Folloni Fernandes, Vanderson Rocha, João Bosco Oliveira, Magda Carneiro‐Sampaio	17
11	Prospective Assessment of Bone Turnover and Clinical Bone Diseases After Allogeneic Hematopoietic Stem-Cell Transplantation 2010 ·Transplantation ·Anna D. Petropoulou, Raphaël Porcher, (unknown), Agnès Devergie, Thomas Funck‐Brentano, Patricia Ribaud, (unknown), Vanderson Rocha, Régis Peffault de Latour, Philippe Orcel, Gèrard Socié, Marie Robin	15
12	Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later 2009 ·Current Opinion in Oncology ·Mohamad Mohty, Vanderson Rocha, Patrice Chevallier, Jean‐Luc Harousseau, Arnon Nagler	5
13	WITHDRAWN: New Approaches For Improving Engraftment After Cord Blood Transplantation 2009 ·Biology of Blood and Marrow Transplantation ·Vanderson Rocha, (unknown)	3
14	Donor CTLA-4 +49 A/GGG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations 2007 ·Blood* ·(unknown), Marc Busson, Virginia Lepage, Dominique Charron, Antoine Toubert, Pascale Loiseau, Régis Peffault de Latour, Vanderson Rocha, Gèrard Socié	31
15	Low-dose Thoracoabdominal Irradiation for the Treatment of Refractory Chronic Graft-versus-Host Disease 2005 ·Transplantation ·Marie Robin, Philippe Guardiola, T. Girinsky, (unknown), Hélène Espérou, Patricia Ribaud, Vanderson Rocha, Federico Garnier, Gèrard Socié, Éliane Gluckman, Agnès Devergie	14
16	Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia 2003 ·British Journal of Haematology ·Xiaxin Li, François Leteurtre, Vanderson Rocha, Philippe Guardiola, Roland Berger, Marie‐Thérèse Daniel, (unknown), Odile Maarek, G. Le Roux, Pauline de La Salmonière, Patrice Richard, Éliane Gluckman	36
17	Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 2003 ·Journal of Clinical Oncology ·Olle Ringdén, Myriam Labopin, Norbert Claude Gorin, Katarina Le Blanc, Vanderson Rocha, Éliane Gluckman, (unknown), William Arcese, Jaak M. Vossen, (unknown), Catherine Cordonnier, Francesco Frassoni	135
18	Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation 1999 ·Clinical Infectious Diseases ·Patricia Ribaud, Claude Chastang, Jean‐Paul Latgé, (unknown), Nathalie Parquet, (unknown), (unknown), Vanderson Rocha, Francis Derouin, Gérard Socié, (unknown)	176
19	Leucemia mielóide aguda do adulto: análise retrospectiva de 99 casos 1995 ·Evandro M. Fagundes, Vanderson Rocha, (unknown), (unknown), (unknown), (unknown), Marcos Borato Viana	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact